BCAX Bicara Therapeutics Inc. Common Stock
Healthcare$21.98+1.38%ClosedMarket Cap: $1.20B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$28.60
Target (Median)
$28.00
Target Range
$18.00 - $42.00
Upside from current price: 30.1%
Rating Distribution
3 Strong Buy9 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | Goldman Sachs | maintain | Neutral | Neutral |
| 2026-05-12 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-03-31 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-31 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-03-31 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-31 | Goldman Sachs | maintain | Neutral | Neutral |
| 2026-03-31 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-01-13 | Wedbush | maintain | Outperform | Outperform |
| 2025-11-11 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2025-08-22 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-2.94 | $0.00 | 10 |
| Fri Dec 31 | $-3.70 | $0.00 | 10 |
| Sun Dec 31 | $-3.53 | $41.5M | 10 |
| Mon Dec 31 | $-2.49 | $197.3M | 4 |